Universit Pierre Et Marie Curie competitive analysis

Explore Universit Pierre Et Marie Curie's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Feb 19, 2026
Patent NumberPublication DateTitleTotal Oppositions
Nov 2, 2022Agents For Use In The Treatment Of Retinal Inflammation1
Nov 24, 2021Implant And Guide1
Oct 27, 2021Interleukin-2 For Treating Food Allergy1
Jan 20, 2021Use Of A Reverse-Transcriptase Inhibitor In The Prevention And Treatment Of Degenerative Diseases1
May 8, 2019Phytoecdysones For Use In Improving The Muscle Quality Of Obese And/Or Sarcopenic Mammals1
Aug 1, 2018Use Of Low Dose Il-2 For Treating Autoimmune - Related Or Inflammatory Disorders1
Mar 28, 2018Specific Nanostructured Material, As A Protective Coating For Metal Surfaces.1
Jul 12, 2017Method And System For Determining A Location Of A Reflecting Scatterer In A Medium1

Latest PTAB cases involving Universit Pierre Et Marie Curie

Discover the latest PTAB cases involving Universit Pierre Et Marie Curie, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Universit Pierre Et Marie Curie with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Feb 19, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
UNIVERSIT PIERRE ET MARIE CURIE PARIS - 5 - -
KONGSBERG MARITIME53 - -
LORENZ SEIDLER GOSSEL RECHTSANWALTE PATENTANWALTE PARTNERSCHAFT MBB6 - - -
STRAWMAN349 - - -